Heidar Tavilani
Associate Professor, Urology and Nephrology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
Maryam Esfahani
PhD Candidate, Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
Vol 8: Special Issue in National Hypertension Treatment 2012:S212-S216
ARYA Atheroscler0020121220Gene polymorphism and hypertension452452ENHeidarTavilaniMaryamEsfahaniPhD Candidate, Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran. esfahanimr21@yahoo.com2012061820120701Hypertension is a significant health problem worldwide and affects more than 20% of the adult population. This disorder has an important role in morbidity and mortality of heart and kidney disease patients. It is believed that essential hypertension is a multifactorial and polygenic disease; resulting from an interplay between environmental and genetic factors. In this paper, we will review studies that have inspected new genome screen and introduced a new viewpoint on candidate genes of essential hypertension. We discuss on polymorphism of candidate genes which related in the pathogenesis of hypertension and take from experimental models or knowledge of the pathophysiology. Study on genetic factors of hypertension may be developing new treatment for these patients. Keywords: Essential Hypertension, Cardiovascular Disease, Gene, Candidate Gene, Polymorphism
Refbacks
There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.